Clinical trial
PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT)…
NCT00274638 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00274638 |
|---|---|
| Title | PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM) |
| Official title | A Prospective, Randomised, Open-Label, Blinded-Endpoint, Parallel Group 6-week Treatment Study Comparing Telmisartan Combined With Hydrochlorothiazide (40 mg/12.5 mg or 80 mg/12.5 mg) Tablets With Losartan Combined With Hydrochlorothiazide (50 mg/12.5 mg) Tablets Using Ambulatory Blood Pressure… |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug, Procedure |
| Interventions | Telmisartan & Hydrochlorothiazide, Losartan & Hydrochlorothiazide, ABPM |
| Enrollment | 805 |
| Start date | Jul 1, 2002 |
| Primary completion | Jul 1, 2003 |
| First posted | Jan 11, 2006 |
| Last update posted | Dec 9, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: